Abstract Bone loss induced by inflammation is one of the complications after biomaterial implantation.
Introduction
Bone loss induced by inflammation is one of the complications after biomaterial implantation into the hard tissue. Pro-inflammatory cytokines interleukin-1 (IL-1) and interleukin-6 (IL-6) exhibit a pro-osteoclastogenic effect in response to implant-derived wear particles. IL-6 recruits and activates osteoclasts and may therefore leads to bone resorption and the loss of implant fixation [1] . Interleukin (IL-8) has been described as a pro-inflammatory mediator in gingivitis [2] . Interleukin-10 (IL-10) is an anti-inflammatory cytokine with pleiotropic effect on immunoregulation and inflammation [3] . The role of β -defensin (BD)-1, BD-2, BD-3 in immune defence against oral infection in cases of biomaterial implantation is not completely defined. There are varying data regarding the expression of cytokines and defensins into the bone tissue around the different bioceramic implants is little discussed. 3 To whom any correspondence should be addressed The aim of this experiment was to research changes in distribution and appearance of proinflammatory cytokines and anti-inflammatory proteins in the lower jaw and tibial bone of experimental rabbits 3 months after the implantation of different biomaterials.
Material and methods
The Animal Ethics Committee of Latvian Food and Veterinary Administration approved the use of 4 Californian male rabbits for this morphofunctional study. Commercial biomaterial and biomaterials produced in Riga Technical University Biomaterial Innovation and Development centre were used in the experiment.
The rabbits received general anaesthesia with Sol. Ketamini (15 mg/kg) and Sol. Dormicum (2 mg/kg), local anaesthesia with Sol. Midazolami (0.5 mg/kg) and Sol. Articaini (5 mg/kg). After raising mucoperiosteal flap, the channel was drilled using 2.0 mm diameter trephine and intraosseal implantation of the following biomaterials were performed: pure hydroxyapatite (HAp) tablet, HAp tablet covered by polycaprolactone (PCL), unburned HAp granules, HAp granules burned under 1150 0 C, commercial polymethylmethacrylate (PMMA) bone cement (Biomet Bone Cement R), PMMA cement, α-Tricalcium phosphate (α-TCP) cement I with pH6 and α-TCP cement II with pH7. The control site was similarly prepared and closed but no biomaterials were inserted.
Three months afterwards, the euthanasia of rabbits was performed by air embolisation and blocks of bone and soft tissue were harvested from experimental and control sites using diamond disc. Tissue were embedded into the paraffin, cut into 5 μm thick slices and prepared for detection of the interleukins: interleukin-1 (IL-1, working dilution 1:1000, abcam, UK), interleukin-6 (IL-6, working dilution 1:50, Santa Cruz Biotechnology, Inc), interleukin-8 (IL-8, working dilution 1:50, Santa Cruz Biotechnology, Inc), interleukin-10 (IL-10, working dilution 1:400, abcam, UK) using biotin-streptavidin immunohistochemistry (IHC) [4] . Innate immunity in rabbits' bones was detected by β -defensin 2 (BD-2, working dilution 1:100, RD systems, UK), β defensin 3 (BD-3, working dilution 1:100, Life Span Biosciences), β defensin 4 (BD-4, working dilution, 1:150, Santa Cruz Biotechnology, Inc) using IHC. Routine staining for haematoxylin and eosin (H/E) was performed for each case [5] . Structure quantification was done applying the semi -quantitative counting method [6] .
Results
Routine histological examination revealed bone developing zones and signs of bone-implant contact in the experimental tissue with such biomaterials as pure HAp, HAp tablet covered by PCL, commercial PMMA bone cement and unburned HAp granules (Figure 1) . In bone tissue samples with α-TCP cements biomaterial, the regions of ossification were less pronounced but in tissue with uncommercial PMMA cement, the ossification zones were not detected at all. Expression of defensins and interleukins in the experimental and control tissue was variable. Marked expression of BD-2 and BD-3 was observed in the tissue with pure HAp (Figure 2) . BD-4 (β-defensin-4) expression was more pronounced in the tissue with commercial PMMA bone cement ( 
Discussion
Our experimental study showed that biomaterials such as commercial PMMA cement, HAp covered by PCL and α-TCP cement I influence the increase in the expression of IL-10 and IL-6. Weak expression of IL-10 we revealed in experimental tissue with pure and unburned HAp material. As IL-10 is true anti-inflammatory cytokine, its absence suggests the absence of inflammation in the bone. However, any variation of IL-10 level should be evaluated as individual response from host tissue. The research of Ninomiya (2001) demonstrates that HAp and HA/TCP (hydroxyapatite/tricalcium phosphate) particles are capable of stimulating the expression and secretion of cytokines IL-6 and proteases that increase bone resorption [7] . The augmentation in IL-8 expression was revealed only in bone tissue with commercial PMMA, whereas in the experiment with other biomaterials it was very weak. The expression of pro-inflammatory cytokine IL-1 in our experimental material was similarly distinct in both commercial and uncommercial PMMA bone cements, α-TCP cement (pH6) and HAp tablet covered by PCL. IL-1 is essential protein for the bone resorption but IL-8 is suggested to be less potential for this function [8] .
β-defensins 1-3 were first described in the osteoblast cell cultures [9] with dominance of defensin 1 and 2. With regard to the reaction of BD-2, BD-3 and BD-4 in our study, the activity was varying. We suggest a role of defensins in traumatic injury could be important in case of biomaterial implantation in the bone.
Conclusion
Bone developing zones, signs of bone-implant contact and low expression of proinflammatory cytokine IL-1, IL-6 and anti-inflammatory cytokine IL-10 in experimental tissue with pure HAp and unburned HAp implants indicate a potential advantage of this material in terms of its biocompatibility over the other materials used in our study.
